NFKB1 and Sepsis: miR-146b from MSC-EVs targeted interleukin (IL)-1 receptor-associated kinase (IRAK1) leading to the inhibition of NF-κB activity and subsequent lessening of pro-inflammatory response in sepsis-associated AKI [87].